Atricure Inc (ATRC) 15.29 $ATRC AtriCure Announces the

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2016 at 1:23 PM

Atricure Inc (ATRC) 15.29 $ATRC

AtriCure Announces the First Patient Enrolled in the FROST Cryoanalgesia Study
BusinessWire - Tue Jun 21, 7:00AM CDT
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced the first patient has been enrolled in the FROST study at William Beaumont Hospital, Dearborn, MI. This company-sponsored trial will evaluate intraoperative cryoanalgesia therapy using cryoablation in conjunction with standard of care (SOC) pain management compared to SOC alone.
ATRC: 15.29 (+0.10)

AtriCure to Present at the UBS Global Healthcare Conference
BusinessWire - Mon May 02, 3:01PM CDT
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that it will present at the UBS Global Healthcare Conference at the Grand Hyatt in New York on Monday, May 23, 2016. Management is scheduled to present at 11:00 a.m. Eastern Time. A live audio webcast of the presentation may be accessed by visiting the Investors page of AtriCure's corporate website at www.atricure.com. A replay of the presentation will be available for 90 days following the presentation.
ATRC: 15.29 (+0.10)

AtriCure Reports First Quarter 2016 Financial Results
BusinessWire - Thu Apr 28, 3:05PM CDT
--U.S. sales of $28.3 million - up 23.3%
ATRC: 15.29 (+0.10)

AtriCure Announces $25 Million Term Loan with Silicon Valley Bank
BusinessWire - Thu Apr 28, 3:01PM CDT
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that it has entered into an amended and restated term loan and revolving line of credit agreement with Silicon Valley Bank, providing access to a new $25 million five-year term loan, as well as renewing a $15 million revolving line of credit.
ATRC: 15.29 (+0.10)

AtriCure Receives FDA Clearance for New AtriClip(R) Device
BusinessWire - Tue Apr 26, 7:00AM CDT
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the AtriClip PRO2 Left Atrial Appendage (LAA) Exclusion System. The new AtriClip PRO2 system has increased functionality which enhances the capability to occlude the LAA during minimally-invasive surgical (MIS) procedures.
ATRC: 15.29 (+0.10)

New Strong Buy Stocks for April 19th
Zacks Equity Research - Zacks Investment Research - Tue Apr 19, 8:33AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
BMA: 73.51 (-1.62), BV: 4.16 (+0.01), ANCX: 22.03 (-0.20), MTGE: 16.43 (+0.07), ATRC: 15.29 (+0.10)

What Falling Estimates & Price Mean for INSYS Therapeutics (INSY)
Zacks Equity Research - Zacks Investment Research - Fri Apr 15, 4:59PM CDT
INSYS Therapeutics has witnessed a significant price decline in the past four weeks and negative estimate revisions, making it time for investors to sell it off.
INSY: 15.94 (+0.29), ATRC: 15.29 (+0.10)

AtriCure Announces 510(k) Clearance for the cryoFORM(TM) Cryoablation Probe
BusinessWire - Tue Apr 12, 7:00AM CDT
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that it has received 510(k) clearance for the cryoFORM cryoablation probe, which offers increased probe flexibility to adapt to a variety of surgical ablation procedures. The probe was previously launched in October 2015 in the European market under a CE mark.
ATRC: 15.29 (+0.10)

AtriCure to Announce First Quarter 2016 Financial Results
BusinessWire - Tue Apr 05, 3:01PM CDT
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, will release its financial results for the first quarter of 2016 on Thursday, April 28, 2016.
ATRC: 15.29 (+0.10)

New Strong Buy Stocks for March 29th
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 8:06AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
BPMC: 22.34 (+0.23), BXE: 0.83 (-0.03), BKCC: 8.31 (-0.05), AKAO: 3.71 (-0.22), ATRC: 15.29 (+0.10)

New Strong Buy Stocks for March 21st
Zacks Equity Research - Zacks Investment Research - Mon Mar 21, 9:04AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
BV: 4.16 (+0.01), ESIO: 6.94 (+0.17), CIDM: 1.68 (+0.07), ATRC: 15.29 (+0.10), CGNT: 1.06 (+0.05)

Phibro Animal Health (PAHC) in Focus: Stock Jumps 5.1%
Zacks Equity Research - Zacks Investment Research - Mon Mar 21, 7:35AM CDT
Phibro Animal Health Corporation (PAHC) was a big mover last session, as the company saw its shares rise over 5% on the day.
PAHC: 20.72 (+0.09), ATRC: 15.29 (+0.10)

Shares of ATRC Down 16.4% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Mar 07, 9:32AM CST
SmarTrend identified a Downtrend for AtriCure (NASDAQ:ATRC) on January 8th, 2016 at $20.08. In approximately 2 months, AtriCure has returned 16.36% as of today's recent price of $16.79.
ATRC: 15.29 (+0.10)

AtriCure Down 19.0% Since SmarTrend Downtrend Call (ATRC)
Comtex SmarTrend(R) - Tue Feb 09, 10:17AM CST
SmarTrend identified a Downtrend for AtriCure (NASDAQ:ATRC) on January 8th, 2016 at $20.08. In approximately 1 month, AtriCure has returned 19.00% as of today's recent price of $16.26.
ATRC: 15.29 (+0.10)

AtriCure to Announce Fourth Quarter and Full Year 2015 Financial Results
BusinessWire - Mon Feb 01, 3:00PM CST
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, will release its financial results for the fourth quarter and full year 2015 on Tuesday, February 23, 2016.
ATRC: 15.29 (+0.10)

Downtrend Call Working As AtriCure Stock Falls 16.6% (ATRC)
Comtex SmarTrend(R) - Fri Jan 29, 10:48AM CST
SmarTrend identified a Downtrend for AtriCure (NASDAQ:ATRC) on January 8th, 2016 at $20.08. In approximately 3 weeks, AtriCure has returned 16.56% as of today's recent price of $16.75.
ATRC: 15.29 (+0.10)

AtriCure to Present at the Leerink Global Healthcare Conference
BusinessWire - Thu Jan 21, 7:00AM CST
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that it will present at the Leerink Global Healthcare Conference at the Waldorf Astoria Hotel in New York on Thursday, February 11, 2016. Management is scheduled to present at 8:05 a.m. Eastern Time. A live audio webcast of the presentation may be accessed by visiting the Investors page of AtriCure's corporate website at www.atricure.com. A replay of the presentation will be available for 90 days following the presentation.
ATRC: 15.29 (+0.10)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wisconsin Chefs Transform Pizza with Crave Brothers Cheese

Reimagining Pizza with Wisconsin's Best Cheeses It's not every day you see a pizza challenge that turns a staple of Friday nights into a gastronomic showcase. But that's exactly what's happening in Wisconsin as chefs flex their creativity using Crave Brothers Farmstead Cheese. This is no ordinary cheese-and-pepperoni affair—these culinary pros are cooking up pizzas with...

Fiber Giants Unite to Boost Connectivity in Montana

Montana's Broadband Transformation Takes a Leap Folks in Northwest Montana, take note. Vero Fiber and MontanaSky have tied the knot, officially sealing a merger that doesn't just unite two reputable broadband providers but promises to shake up the internet game across the region. Just ask anyone who's tried to stream a movie during peak hours in Flathead Valley. A...

Texas A&M-San Antonio's Research Expansion Momentum

Texas A&M-San Antonio's Rising Research Ambitions A rainy day in San Antonio and Texas A&M University-San Antonio seems to have set the stage for more than just another semester of record enrollment. They’ve just rolled in with an exhilarating $8 million in external grants this fiscal year, more than doubling last year’s haul of $3.6 million, in a bid to push their...

Comparent Unveils Key Insights with Top 100 List

The Ebb and Flow of Vacation Rental Giants Ever noticed how some industries just sneak up and suddenly transform landscapes? Vacation rental management is one of those sneaky offenders. At the forefront of keeping tabs on this bustling sector, Comparent just dropped a meaty second annual roster—the Comparent 100—showcasing the biggest players flexing their muscles in...

October Becomes a Beacon for Grieving Families

October: A Month for Heartfelt Observance There's a profound resonance when October rolls around, especially for families who've faced the heartbreak of pregnancy or infant loss. Thanks to Postpartum Support International (PSI), the month serves as more than just a page in a calendar—it's a solidarity rallying cry for awareness and remembrance. The group's commitment to...

New Tools Arm Manufacturers in Additive Arena

Diving Headfirst into Additive Manufacturing Standards Additive manufacturing (AM)—it's not just another tech buzzword. It's revolutionizing everything from life-saving medical devices to cutting-edge aerospace components. But as with any game-changing innovation, there's a wild west era before standards reign in the chaos. Enter ANSI and America Makes, offering new...

Nelson-Jameson Boosts Cold Storage in California Move

An Icy Boost for the West Coast Dairy Player Every now and then, a company gets its cold storage game just right. Nelson-Jameson has added fresh muscle to its Turlock facility in California, making waves with serious logistical upgrades. The company's dogged pursuit of better operational efficiency in dairy processing isn't just about bragging rights. It's plain old good...

Ace Hardware Ups the Stakes with Rewards Days Event

Ace Hardware: Doubling Down with Rewards Ace Hardware's rolling out the red carpet for its loyal customers. Imagine this: exclusive deals on trusted brands and double points on purchases—an incentive any savvy shopper would jump at. From October 6 to 7, those in the Ace Rewards circle have the chance to nab some hefty savings and perks, a move that's more than just a...

Kroger, Imprint Team Up for AI-Driven Mastercard

Kroger Teams Up with Imprint for New Credit Card Kroger’s at it again, folks. They're rolling out a shiny new Mastercard, and it's not just any plastic—it’s powered by the AI-driven platform Imprint. Now, what does this mean for you and me? Well, if you're a frequent flyer at Kroger aisles, you might want to pay attention because this card’s offering point...

Nukleus Launches Unified Platform for Athletes' Business

Leveling the Business Field for Athletes Athletes spend their lives fighting for every inch on the field, and now Nukleus is giving them the tools to hold ground off it. Why should they be the last ones to know their own business? Ashton Jeanty and Nukleus got tired of that narrative and kicked off a platform today with a real promise: putting an athlete's entire business...